Day One Biopharmaceuticals Inc (DAWN)
Cost of Revenue
$17.21M
TTM · Period ending: · USD
DAWN Cost of Revenue
Latest reported$17.21Mperiod ending
Latest reported$17.21Mperiod ending
DAWN TTM Cost of Revenue ($0.00 → $17.21M)
TTM cost of revenue
High-resolution chart · PNG
DAWN cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 17,210,000 | |
| 14,111,000 | |
| 11,221,000 | |
| 8,163,000 | |
| 5,279,000 | |
| 2,297,000 | |
| 707,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |